Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer 2025-08-25 08:00
Antengene Announces 2025 Interim Financial Results Highlighting Encouraging Data from Mid/Late-Stage Clinical Programs and Its Innovative TCE Technology Platform 2025-08-22 18:14
Angel Yeast Cup Finals and Industry Development Conference Concludes 2025-08-22 18:04
Biosyngen Unveils Innovative Strategies for Next-Generation TIL Therapies in Asia Bio 2025 Singapore 2025-08-22 09:55
BioDlink's Bevacizumab Approved for Market Launch in Indonesia, Marking Fourth Consecutive Emerging Market Authorization 2025-08-21 20:00
SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health 2025-08-21 20:00
Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results 2025-08-21 18:02
SINGZYME WINS 2025 AMGEN X NSG GOLDEN TICKET FOR BREAKTHROUGH BIOCONJUGATION PLATFORM 2025-08-21 17:38
GC Biopharma's Study on Hunterase Lysosomal Delivery Mechanism Published in SCIE-Indexed Journal 2025-08-21 13:00
Debut of new form of health supplement product! WCC biomedical collaborate with Synmosa toward the niche market! 2025-08-21 09:23
Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth 2025-08-21 08:23
Cell therapy is promising in treating psychiatric disorders, such as depression. -- A proof-of-principle study published in "Cell Stem Cell" by the laboratory of Dr. Chen, founder of UniXell Biotech, suggests this. 2025-08-20 20:49
Mabwell's CDH17-targeting ADC 7MW4911 Receives IND Clearance from FDA 2025-08-19 22:00
WuXi Biologics Reports Solid 2025 Interim Results 2025-08-19 20:35
Nature Medicine Publishes Results of Phase II Study of Sacituzumab Tirumotecan Plus Tagitanlimab as First-Line Therapy for NSCLC 2025-08-19 20:09
Nilesh Shah joins Illumina as Head of Region, AMEA 2025-08-19 14:14
Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma 2025-08-19 13:26
Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease 2025-08-19 11:00
RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries 2025-08-19 08:00
Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP). 2025-08-18 21:00
1 23 24 25 26 27 525